Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q72742180)
Watch
English
Therapeutic trials in multiple sclerosis
scientific article published on 01 August 1984
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6205737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
title
Therapeutic trials in multiple sclerosis
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6205737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
main subject
multiple sclerosis
1 reference
based on heuristic
inferred from title
author name string
J H Noseworthy
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6205737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
T P Seland
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6205737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
G C Ebers
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6205737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
publication date
1 August 1984
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6205737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
published in
Canadian Journal of Neurological Sciences
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6205737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
volume
11
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6205737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
issue
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6205737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
page(s)
355-362
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6205737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
cites work
Nuclear magnetic resonance imaging of the brain in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Plasmapheresis in multiple sclerosis: preliminary study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prolonged azathioprine treatment of non-remitting multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intensive immunosuppression in the treatment of multiple sclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multiple sclerosis unaffected by azathioprine in pilot study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New diagnostic criteria for multiple sclerosis: guidelines for research protocols
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic trial of Imuran (azathioprine) in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of antithymocyte globulin in acute relapses of multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
First results of immunotherapy with immunoglobulin G in multiple sclerosis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term treatment of multiple sclerosis with corticotrophin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Azathioprine in treatment of multiple sclerosis. Final results of a 41/2-year controlled study of its effectiveness covering 115 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transfer-factor therapy in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multiple sclerosis: trial of a synthetic polypeptide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nuclear magnetic resonance imaging in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term treatment of multiple sclerosis with azathioprine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Study of CSF Idiotypes in Multiple Sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of immunity in multiple sclerosis: a double-blind levamisole-placebo controlled study in 85 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Myelin basic protein administration in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The design of clinical studies to assess therapeutic efficacy in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hyperbaric-oxygen treatment of multiple sclerosis. A randomized, placebo-controlled, double-blind study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Plasmapheresis in multiple sclerosis: preliminary findings
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. I. Demonstration of similar or identical idiotypes on IgG molecules and T-cell receptors with specificity for the same alloantigens
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Short-term intensive cyclophosphamide treatment in multiple sclerosis. A retrospective controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Levamisole in multiple sclerosis, with special reference to immunological parameters
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transfer factor in treatment of multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Murine models of multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multifocal CT enhancement in MS.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term transfer-factor treatment for multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of intraocular inflammatory disease with cyclosporin A
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Individual Antigenic Specificity of Isolated Antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intrathecal interferon in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Failure of basic protein therapy for multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Myelin basic protein treatment of experimental allergic encephalomyelitis in monkeys
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biological effects of cyclosporin A: A new antilymphocytic agent
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Penicillamine in multiple sclerosis. Therapeutic trial and design of uncontrolled pilot drug study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclosporin A - Usefulness, Risks and Mechanism of Action
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suppression of experimental allergic encephalomyelitis by interferon
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1017%2FS0317167100045704
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1017/S0317167100045704
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6205737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
PubMed publication ID
6205737
1 reference
stated in
Europe PubMed Central
PubMed publication ID
6205737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6205737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit